DarioHealth (DRIO) Receivables (2014 - 2026)

DarioHealth (DRIO) has reported Receivables for 13 consecutive years, with $879000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Receivables fell 53.86% year-over-year to $879000.0; the trailing twelve-month figure through Jun 2026 stood at $879000.0 (down 53.86% YoY), and the FY2025 full-year result was -$516000.0, down 116.52% from the prior year.
• Receivables declined to $879000.0 in Q2 2026 per DRIO's latest filing, from $2.3 million in the prior quarter.
• Across five years, Receivables topped out at $9.3 million in Q1 2024 and bottomed at -$822000.0 in Q1 2023.
• Historically, Receivables has averaged $3.8 million across 5 years, with a median of $2.7 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Receivables jumped 5125.33% in 2022, then tumbled 110.49% in 2023.
• Over 5 years, Receivables stood at $8.3 million in 2022, then sank by 78.62% to $1.8 million in 2023, then surged by 162.24% to $4.7 million in 2024, then plunged by 58.95% to $1.9 million in 2025, then tumbled by 54.05% to $879000.0 in 2026.
• According to Business Quant data, Receivables over the past three periods registered $879000.0, $2.3 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.